History of Diabetes: From Ancient Egypt to Modern Medicine

Diabetes has been around for so long that it basically deserves a backstage pass to human history. Long before anyone owned a glucose meter, people noticed a
weird pattern: some folks drank a ton of water, peed like a leaky amphora, lost weight fast, and got sick in a way that felt… distinct. The diagnosis tools
were, shall we say, not FDA-cleared. (More on the “taste test” era latermedicine was wild.)

The story of diabetes is a story of pattern recognition becoming biochemistry, which then becomes technology, and finally becomes
software that politely nags you every five minutes. It’s also a story of peoplepatients, clinicians, and researcherswho kept pushing when the best
available treatment used to be “eat almost nothing and hope for the best.”

What “Diabetes” Means (and Why the History Matters)

“Diabetes” isn’t one single disease, even though it often gets talked about like a single villain in a medical drama. It’s a group of conditions defined by
chronically elevated blood glucose (blood sugar), with different causes and different trajectories. Today we talk about type 1 diabetes
(an autoimmune attack on insulin-producing beta cells) and type 2 diabetes (insulin resistance plus a pancreas that can’t keep up), among
other forms. But for most of history, diabetes was defined by what people could see: relentless thirst, frequent urination, weight loss, weakness, and a
frighteningly predictable decline.

The history matters because it shows how medicine learns. Diabetes forced doctors to connect symptoms to organs, then to chemicals, then to measurable data.
It helped launch modern endocrinology, accelerated laboratory diagnostics, and eventually drove innovations like insulin pumps, continuous glucose monitors
(CGMs), and closed-loop “artificial pancreas” systems.

Ancient Clues: Egypt, India, and the Mystery of Sweet Urine

Ancient Egypt: “Too Great Emptying of Urine”

One of the oldest references to a diabetes-like illness appears in ancient Egyptian medical writings dating back roughly 3,500 years. The descriptions weren’t
using words like “glucose” (shocking, I know), but they recognized excessive urination as a signature feature. In a world without lab tests, noticing that
pattern was a huge clinical leap.

Ancient India: The Ant Test and “Honey Urine”

In ancient India, physicians described a condition called madhumehaoften translated as “honey urine.” They noticed that urine could attract ants,
which is both grim and oddly efficient. That observation was essentially an early “biomarker”: sugar spilling into urine, visible through the behavior of
insects. Not exactly a randomized controlled trial, but it was a real-world clue that something sweet was happening inside the body.

Greco-Roman Medicine: Naming the Problem

Centuries later, the Greek physician Aretaeus of Cappadocia gave the condition a name: diabetes, meaning “a siphon,” reflecting the dramatic
flow of urine. Early medical theories often blamed the kidneys, because that’s where the most obvious symptoms showed up. The body was basically seen as a
plumbing system with a serious leak.

From Taste Tests to Chemistry Sets: 1600s–1800s

“Mellitus” Enters the Chat

By the 1600s, the story gets both more accurate and more disturbing. The term diabetes mellitus (“honey-sweet diabetes”) was popularized
after physicians noted the sweetness of urine and sometimes even blood. Yes, some of that was discovered the old-fashioned way: tasting. If you’re grateful
for modern lab analyzers, you’re not alone.

Sugar Becomes the Prime Suspect

In the 1700s, researchers confirmed that the sweetness wasn’t poeticit was chemical. Excess sugar was present in urine and blood. This was a major turning
point: diabetes wasn’t just “too much urine.” It was a disorder of metabolism.

The Pancreas Steps into the Spotlight

The 1800s transformed diabetes research because physiology transformed medicine. Scientists began mapping organs to functions, and diabetes started drifting
away from kidney-centric explanations. The pancreas became increasingly suspicious. The discovery of the islets of Langerhans (clusters of cells in the
pancreas) and experiments showing that removing the pancreas caused diabetes-like symptoms in animals provided strong evidence that something produced by the
pancreas controlled sugar metabolism.

This era is where diabetes shifts from a tragic clinical observation to a solvable biological puzzle. The “what” (sweet urine, weight loss, thirst) was
finally being connected to the “why” (a missing or ineffective hormone).

The Insulin Revolution: 1921–1922

From Hypothesis to Hormone

In the early 1900s, researchers strongly suspected that the pancreas made a substance that regulated blood sugar. The problem was extracting it safely.
Pancreatic extracts were often toxic or inconsistentlike trying to bake a soufflé while wearing oven mitts and riding a bicycle.

Banting, Best, and the “Thick Brown Muck” Era

In 1921, Frederick Banting and Charles Best successfully produced a pancreatic extract that lowered blood glucose in diabetic dogs, working with the broader
University of Toronto team that included J.J.R. Macleod and, crucially, biochemist James Collip, who helped refine purification. The result: insulin moved
from theory to therapy. One year later, the first successful treatments in humans changed diabetes from a near-certain death sentence (especially for children
with what we now call type 1 diabetes) into a survivable condition.

Leonard Thompson and a New Medical Reality

The first widely cited human treatment was Leonard Thompson, a teenage boy with severe diabetes, who received insulin in early 1922. Early doses were
imperfect, but rapid improvements in purification and production made insulin a true breakthrough. In short: the “before” and “after” of diabetes care became
painfully clear.

Scaling Insulin: From Lab Bench to Bottles

A medical miracle is only a miracle for one person unless you can manufacture it. In 1922, commercial insulin production ramped up, using animal pancreases
(primarily pigs and cattle). Standardization improved. Purity improved. Supply chains got… meaty. The transition from fragile lab extracts to reliable dosing
didn’t just save livesit created a model for how modern biologic medicines could be produced and distributed.

Life After Insulin: Better, Longer, Complicated

Insulin didn’t “cure” diabetes, but it rewrote the plot. People lived longer, which was the goaland also revealed the long-term complications of chronic high
glucose: damage to eyes, kidneys, nerves, heart, and blood vessels. This forced medicine to become more precise. It wasn’t enough to keep someone alive; you
had to keep glucose controlled over decades.

Diabetes care began expanding into education, nutrition science, and systematic follow-up. Clinics specialized. Standards emerged. Researchers pushed for
better insulin formulations and delivery methods, and the idea of diabetes as a long-term condition with preventable complications took hold.

Measuring the Invisible: Glucose Meters and A1C

Why Spot Checks Weren’t Enough

For much of history, “How well controlled is your diabetes?” was answered with a shrug, a symptom report, or a urine test that lagged behind real blood
glucose changes. That’s like checking the weather by reading yesterday’s newspaper.

The Rise of Home Glucose Monitoring

In the 1970s, home glucose monitoring began to take off, changing patient autonomy. Instead of waiting for clinic visits, people could see what food,
exercise, stress, and medication were doing in real time (or close enough). It was a shift from “doctor knows best” to “data helps both of us.”

HbA1c: The “Report Card” for the Past Few Months

HbA1c (often just “A1C”) became a cornerstone because it reflects average glucose control over roughly two to three months. It gave clinicians and patients a
longer-view metricless swayed by the “I ate a salad today, I swear” effect. This single test helped transform diabetes care from reactive to strategic.

From Needles to Algorithms: Pumps, CGMs, and the Artificial Pancreas

Insulin Pumps: Basal, Bolus, and Freedom

Insulin pumps are small computerized devices that deliver rapid-acting insulin through a cannula under the skin. They provide a continuous basal
rate and patient-triggered bolus doses for meals or corrections. For many, pumps made insulin delivery more flexible andwhen used wellmore
precise than multiple daily injections.

Continuous Glucose Monitoring: A Number with a Timeline

CGMs changed the emotional texture of diabetes management. Instead of a single number, you get trend arrows and alerts. You don’t just know you’re at 110you
know you’re at 110 and drifting down, which is the difference between “cool” and “get a snack before this becomes a problem.”

Closed-Loop Systems: The Not-Quite-Sci-Fi Artificial Pancreas

The “artificial pancreas” concept links CGM data to automated insulin delivery, adjusting dosing to mimic the exquisite control of a healthy pancreas. It’s not
magicpeople still have to manage meals, device maintenance, and real lifebut it’s a remarkable example of biology meeting engineering meeting software.

Modern Diabetes Medicine: Beyond Insulin

Diabetes treatment today isn’t just “insulin or nothing.” For type 2 diabetes in particular, modern medicine includes multiple classes of medications that
address insulin resistance, glucose production by the liver, glucose absorption in the kidneys, appetite regulation, and more. Some newer therapies overlap
with obesity medicine because weight regulation and glucose regulation are biologically intertwined.

Meanwhile, glucagonanother pancreatic hormonebecame a life-saving emergency treatment for severe hypoglycemia, and research continues to improve how stable,
easy-to-use, and effective these rescue options can be.

Where the Story Is Heading

The next chapters are being written right now: beta cell replacement strategies, immune therapies to preserve remaining insulin production in early type 1
diabetes, smarter closed-loop algorithms, and medications that reduce cardiovascular and kidney risk. If ancient physicians were impressed by ants hovering
over sweet urine, they would have absolutely lost their minds over a sensor that streams glucose data to a phone.

Conclusion: A Long History, a Faster Future

The history of diabetes is a reminder that medicine doesn’t “arrive”it evolves. We went from ancient descriptions of excessive urination to identifying sugar
as the culprit, to linking diabetes to the pancreas, to extracting insulin, to manufacturing it at scale, to building devices that help approximate what the
pancreas does automatically.

And the big theme? Progress happens when observation meets measurement, and measurement meets compassion. The goal has always been the same: fewer symptoms,
fewer complications, more life. The tools just keep getting betterand thankfully, they no longer involve anybody tasting anything.

Experiences Through the Ages: What Living With Diabetes Has Felt Like (Then and Now)

If you want to understand the history of diabetes, it helps to step out of the timeline and into the lived realitywhat it likely felt like to be a patient
before the word “insulin” existed, and what it feels like now that a tiny sensor can text you in the middle of a meeting like, “Hey bestie, we’re trending
upward.”

Imagine ancient Egypt: you’re thirsty all the time, you’re losing weight despite eating, and you’re visiting the latrine so often you basically have a
reserved seat. There’s no blood test, no diagnosis code, no explanation that your beta cells are struggling. The best anyone can do is describe what they see
and try remedies that may soothe symptoms but can’t fix the underlying problem. You’re not “managing a chronic condition.” You’re enduring a mysterious,
draining illness that slowly steals strength.

Fast-forward to the classical world where the condition finally gets a name“diabetes,” the siphon. A name helps, but it also highlights how much is still
unknown. If the body is a set of pipes, then diabetes looks like a plumbing disaster. Treatments might involve diet changes, herbal mixtures, or theories that
sound confident because confidence is cheaper than evidence. The day-to-day experience is still dominated by symptoms: thirst, fatigue, muscle wasting, and a
creeping sense that your body has stopped cooperating.

In the 1600s and 1700s, “experiences” include a uniquely awkward feature: physicians confirming sweetness by taste. It’s hard to overstate what that means for
patients. Beyond the discomfort, it’s a reminder that diabetes was visible to other people in ways that feel personalyour urine becomes evidence, your body
becomes the experiment, and privacy becomes optional. At the same time, chemistry is beginning to translate symptoms into something measurable: sugar. That
shift doesn’t fix diabetes yet, but it validates the patient experience: this isn’t imagination, weakness, or moral failure. It’s physiology.

Then comes the early 1900s, when type 1 diabetesespecially in childrenoften moves terrifyingly fast. Historical accounts of “starvation diets” before insulin
aren’t just medical trivia; they’re a window into a brutal compromise. Families and clinicians tried to stretch life by restricting calories so severely that
patients were kept alive in a state of near-constant hunger. The experience was a trade: fewer calories meant fewer immediate symptoms, but also weakness and
suffering. When insulin arrived, it didn’t simply extend life; it changed what hope looked like. People who had been fading could stabilize. Parents could
imagine birthdays that were more than a maybe.

Modern diabetes experiences are different, but not effortless. Insulin therapy requires decisions: timing, dosing, carb counting, correction factors, exercise
planning, and the occasional emotional negotiation with a slice of pizza. Devices can reduce burden, but they can also add their own quirkssite changes,
alarms at inconvenient times, adhesives that rebel against summer humidity. Still, the overall arc is unmistakable: the center of gravity has shifted from
survival to quality of life, from guessing to data, from isolation to community support and education.

The most striking “experience” thread across centuries is that diabetes has always demanded attention. The difference now is that attention can be shared with
technology, clinicians can act on precise trends, and research continues to push toward therapies that preserve or replace beta cell function. In other words:
the burden is realbut the future is increasingly engineered to lighten it.